{"id":"NCT01722487","sponsor":"Pharmacyclics LLC.","briefTitle":"Open-label Phase 3 BTK Inhibitor Ibrutinib vs Chlorambucil Patients 65 Years or Older With Treatment-naive CLL or SLL","officialTitle":"Randomized, Multicenter, Open-label, Phase 3 Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Versus Chlorambucil in Patients 65 Years or Older With Treatment-naive Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-03","primaryCompletion":"2015-05","completion":"2015-05","firstPosted":"2012-11-06","resultsPosted":"2016-05-04","lastUpdate":"2017-11-30"},"enrollment":269,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Lymphocytic Leukemia","Small Lymphocytic Lymphoma"],"interventions":[{"type":"DRUG","name":"Ibrutinib","otherNames":[]},{"type":"DRUG","name":"Chlorambucil","otherNames":[]}],"arms":[{"label":"Ibrutinib","type":"EXPERIMENTAL"},{"label":"Chlorambucil","type":"ACTIVE_COMPARATOR"}],"summary":"A Randomized, Multicenter, Open-label, Phase 3 Study of the Bruton's Tyrosine Kinase Inhibitor PCI-32765 versus Chlorambucil in Patients 65 Years or Older with Treatment-naive Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma.","primaryOutcome":{"measure":"PFS (Progression Free Survival)","timeFrame":"Analysis was conducted when 15 months had elapsed after the last subject was randomized with the cutoff date of 4 May 2015. The median follow-up time is 18 month.","effectByArm":[{"arm":"Ibrutinib","deltaMin":null,"sd":null},{"arm":"Chlorambucil","deltaMin":18.9,"sd":null}],"pValues":[{"comp":"OG001","p":"<0.0001"}]},"eligibility":{"minAge":"65 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":108,"countries":["United States","Australia","Belgium","Canada","China","Czechia","Ireland","Israel","Italy","New Zealand","Poland","Russia","Spain","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["40266025","36617990","35377947","35014928","34865212","31196847","29880603","28751558","26639149"],"seeAlso":["http://www.pharmacyclics.com"]},"adverseEventsSummary":{"seriousAny":{"events":55,"n":135},"commonTop":["Fatigue","Nausea","Diarrhoea","Anaemia","Cough"]}}